nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.326	0.6	CbGaD
Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.218	0.4	CbGaD
Lomefloxacin—ABCC2—Glyburide—type 2 diabetes mellitus	0.0648	0.329	CbGbCtD
Lomefloxacin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0435	0.221	CbGbCtD
Lomefloxacin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0343	0.174	CbGbCtD
Lomefloxacin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0324	0.164	CbGbCtD
Lomefloxacin—CYP1A2—Losartan—type 2 diabetes mellitus	0.0221	0.112	CbGbCtD
Lomefloxacin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00175	0.724	CbGdCrCtD
Lomefloxacin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000667	0.276	CbGdCrCtD
Lomefloxacin—Sparfloxacin—ABCC2—type 2 diabetes mellitus	0.000567	0.155	CrCbGaD
Lomefloxacin—Pefloxacin—CYP1A2—type 2 diabetes mellitus	0.00044	0.121	CrCbGaD
Lomefloxacin—Enoxacin—CYP1A2—type 2 diabetes mellitus	0.000411	0.113	CrCbGaD
Lomefloxacin—Ofloxacin—ABCC2—type 2 diabetes mellitus	0.000399	0.109	CrCbGaD
Lomefloxacin—Gatifloxacin—ALB—type 2 diabetes mellitus	0.000335	0.0918	CrCbGaD
Lomefloxacin—Ofloxacin—CYP1A2—type 2 diabetes mellitus	0.000266	0.073	CrCbGaD
Lomefloxacin—Levofloxacin—CYP1A2—type 2 diabetes mellitus	0.000266	0.073	CrCbGaD
Lomefloxacin—Ciprofloxacin—CYP1A2—type 2 diabetes mellitus	0.000257	0.0705	CrCbGaD
Lomefloxacin—Norfloxacin—CYP1A2—type 2 diabetes mellitus	0.000216	0.0592	CrCbGaD
Lomefloxacin—Levofloxacin—CYP3A4—type 2 diabetes mellitus	0.000176	0.0483	CrCbGaD
Lomefloxacin—Ciprofloxacin—CYP3A4—type 2 diabetes mellitus	0.00017	0.0467	CrCbGaD
Lomefloxacin—Norfloxacin—CYP3A4—type 2 diabetes mellitus	0.000143	0.0392	CrCbGaD
Lomefloxacin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000498	CcSEcCtD
Lomefloxacin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000106	0.000498	CcSEcCtD
Lomefloxacin—Headache—Glimepiride—type 2 diabetes mellitus	0.000106	0.000497	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000106	0.000497	CcSEcCtD
Lomefloxacin—Cough—Irbesartan—type 2 diabetes mellitus	0.000105	0.000496	CcSEcCtD
Lomefloxacin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000496	CcSEcCtD
Lomefloxacin—Anaemia—Losartan—type 2 diabetes mellitus	0.000105	0.000495	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000105	0.000492	CcSEcCtD
Lomefloxacin—Agitation—Losartan—type 2 diabetes mellitus	0.000105	0.000492	CcSEcCtD
Lomefloxacin—Oedema—Metformin—type 2 diabetes mellitus	0.000105	0.000492	CcSEcCtD
Lomefloxacin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000104	0.000492	CcSEcCtD
Lomefloxacin—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000104	0.000491	CcSEcCtD
Lomefloxacin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00049	CcSEcCtD
Lomefloxacin—Flushing—Ramipril—type 2 diabetes mellitus	0.000104	0.000489	CcSEcCtD
Lomefloxacin—Angioedema—Losartan—type 2 diabetes mellitus	0.000104	0.000489	CcSEcCtD
Lomefloxacin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000104	0.000488	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.000486	CcSEcCtD
Lomefloxacin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000103	0.000485	CcSEcCtD
Lomefloxacin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000103	0.000484	CcSEcCtD
Lomefloxacin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000484	CcSEcCtD
Lomefloxacin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000484	CcSEcCtD
Lomefloxacin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000484	CcSEcCtD
Lomefloxacin—Shock—Metformin—type 2 diabetes mellitus	0.000103	0.000484	CcSEcCtD
Lomefloxacin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000103	0.000483	CcSEcCtD
Lomefloxacin—Malaise—Losartan—type 2 diabetes mellitus	0.000103	0.000483	CcSEcCtD
Lomefloxacin—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000103	0.000483	CcSEcCtD
Lomefloxacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000103	0.000482	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000102	0.000482	CcSEcCtD
Lomefloxacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000482	CcSEcCtD
Lomefloxacin—Vertigo—Losartan—type 2 diabetes mellitus	0.000102	0.000481	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000481	CcSEcCtD
Lomefloxacin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000102	0.00048	CcSEcCtD
Lomefloxacin—Syncope—Losartan—type 2 diabetes mellitus	0.000102	0.00048	CcSEcCtD
Lomefloxacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000102	0.000479	CcSEcCtD
Lomefloxacin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000102	0.000479	CcSEcCtD
Lomefloxacin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000102	0.000478	CcSEcCtD
Lomefloxacin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000102	0.000478	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—SIRT1—type 2 diabetes mellitus	0.000101	0.00251	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000101	0.000475	CcSEcCtD
Lomefloxacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000101	0.000475	CcSEcCtD
Lomefloxacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000474	CcSEcCtD
Lomefloxacin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000101	0.000474	CcSEcCtD
Lomefloxacin—Nausea—Glimepiride—type 2 diabetes mellitus	0.0001	0.000472	CcSEcCtD
Lomefloxacin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.0001	0.000471	CcSEcCtD
Lomefloxacin—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.0001	0.00047	CcSEcCtD
Lomefloxacin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.99e-05	0.00047	CcSEcCtD
Lomefloxacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.98e-05	0.00047	CcSEcCtD
Lomefloxacin—Asthenia—Glyburide—type 2 diabetes mellitus	9.98e-05	0.00047	CcSEcCtD
Lomefloxacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.98e-05	0.00047	CcSEcCtD
Lomefloxacin—Anorexia—Metformin—type 2 diabetes mellitus	9.96e-05	0.000469	CcSEcCtD
Lomefloxacin—Cough—Losartan—type 2 diabetes mellitus	9.93e-05	0.000467	CcSEcCtD
Lomefloxacin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.93e-05	0.000467	CcSEcCtD
Lomefloxacin—Fatigue—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000466	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CALM1—type 2 diabetes mellitus	9.9e-05	0.00246	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.88e-05	0.000465	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000464	CcSEcCtD
Lomefloxacin—Oedema—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000464	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—APOE—type 2 diabetes mellitus	9.86e-05	0.00245	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.86e-05	0.000464	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	9.86e-05	0.00245	CbGpPWpGaD
Lomefloxacin—Pruritus—Glyburide—type 2 diabetes mellitus	9.84e-05	0.000463	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	9.83e-05	0.00244	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	9.83e-05	0.00244	CbGpPWpGaD
Lomefloxacin—Constipation—Valsartan—type 2 diabetes mellitus	9.82e-05	0.000462	CcSEcCtD
Lomefloxacin—Fatigue—Orlistat—type 2 diabetes mellitus	9.78e-05	0.00046	CcSEcCtD
Lomefloxacin—Hypotension—Metformin—type 2 diabetes mellitus	9.77e-05	0.00046	CcSEcCtD
Lomefloxacin—Shock—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000457	CcSEcCtD
Lomefloxacin—Arthralgia—Losartan—type 2 diabetes mellitus	9.68e-05	0.000456	CcSEcCtD
Lomefloxacin—Myalgia—Losartan—type 2 diabetes mellitus	9.68e-05	0.000456	CcSEcCtD
Lomefloxacin—Chest pain—Losartan—type 2 diabetes mellitus	9.68e-05	0.000456	CcSEcCtD
Lomefloxacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.68e-05	0.000455	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.66e-05	0.000454	CcSEcCtD
Lomefloxacin—Anxiety—Losartan—type 2 diabetes mellitus	9.65e-05	0.000454	CcSEcCtD
Lomefloxacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000453	CcSEcCtD
Lomefloxacin—Rash—Bromocriptine—type 2 diabetes mellitus	9.6e-05	0.000452	CcSEcCtD
Lomefloxacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.59e-05	0.000451	CcSEcCtD
Lomefloxacin—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.58e-05	0.000451	CcSEcCtD
Lomefloxacin—Tension—Ramipril—type 2 diabetes mellitus	9.57e-05	0.00045	CcSEcCtD
Lomefloxacin—Discomfort—Losartan—type 2 diabetes mellitus	9.57e-05	0.00045	CcSEcCtD
Lomefloxacin—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.55e-05	0.000449	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000449	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	9.54e-05	0.00237	CbGpPWpGaD
Lomefloxacin—Headache—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.000449	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.52e-05	0.000448	CcSEcCtD
Lomefloxacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.52e-05	0.000448	CcSEcCtD
Lomefloxacin—Nervousness—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000446	CcSEcCtD
Lomefloxacin—Dry mouth—Losartan—type 2 diabetes mellitus	9.47e-05	0.000446	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.46e-05	0.00235	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.46e-05	0.00235	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.45e-05	0.00234	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HMOX1—type 2 diabetes mellitus	9.4e-05	0.00233	CbGpPWpGaD
Lomefloxacin—Anorexia—Irbesartan—type 2 diabetes mellitus	9.4e-05	0.000442	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.39e-05	0.000442	CcSEcCtD
Lomefloxacin—Paraesthesia—Metformin—type 2 diabetes mellitus	9.39e-05	0.000442	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—MAT1A—type 2 diabetes mellitus	9.39e-05	0.00233	CbGpPWpGaD
Lomefloxacin—Muscle spasms—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000441	CcSEcCtD
Lomefloxacin—Confusional state—Losartan—type 2 diabetes mellitus	9.36e-05	0.00044	CcSEcCtD
Lomefloxacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.35e-05	0.00044	CcSEcCtD
Lomefloxacin—Dyspnoea—Metformin—type 2 diabetes mellitus	9.32e-05	0.000438	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.3e-05	0.00231	CbGpPWpGaD
Lomefloxacin—Somnolence—Metformin—type 2 diabetes mellitus	9.29e-05	0.000437	CcSEcCtD
Lomefloxacin—Oedema—Losartan—type 2 diabetes mellitus	9.28e-05	0.000437	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.28e-05	0.000437	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.28e-05	0.000436	CcSEcCtD
Lomefloxacin—Hypotension—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000434	CcSEcCtD
Lomefloxacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.2e-05	0.000433	CcSEcCtD
Lomefloxacin—Dyspepsia—Metformin—type 2 diabetes mellitus	9.2e-05	0.000433	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	9.15e-05	0.00227	CbGpPWpGaD
Lomefloxacin—Tremor—Ramipril—type 2 diabetes mellitus	9.14e-05	0.00043	CcSEcCtD
Lomefloxacin—Shock—Losartan—type 2 diabetes mellitus	9.13e-05	0.00043	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.13e-05	0.00227	CbGpPWpGaD
Lomefloxacin—Urticaria—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000429	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.09e-05	0.000428	CcSEcCtD
Lomefloxacin—Decreased appetite—Metformin—type 2 diabetes mellitus	9.09e-05	0.000428	CcSEcCtD
Lomefloxacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.07e-05	0.000427	CcSEcCtD
Lomefloxacin—Tachycardia—Losartan—type 2 diabetes mellitus	9.06e-05	0.000426	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000426	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	9.05e-05	0.00225	CbGpPWpGaD
Lomefloxacin—Nausea—Bromocriptine—type 2 diabetes mellitus	9.04e-05	0.000425	CcSEcCtD
Lomefloxacin—Fatigue—Metformin—type 2 diabetes mellitus	9.01e-05	0.000424	CcSEcCtD
Lomefloxacin—Urticaria—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000424	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000423	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.97e-05	0.000422	CcSEcCtD
Lomefloxacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.97e-05	0.000422	CcSEcCtD
Lomefloxacin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.000422	CcSEcCtD
Lomefloxacin—Agitation—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000422	CcSEcCtD
Lomefloxacin—Constipation—Metformin—type 2 diabetes mellitus	8.94e-05	0.000421	CcSEcCtD
Lomefloxacin—Angioedema—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000419	CcSEcCtD
Lomefloxacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000417	CcSEcCtD
Lomefloxacin—Anorexia—Losartan—type 2 diabetes mellitus	8.85e-05	0.000416	CcSEcCtD
Lomefloxacin—Vomiting—Glyburide—type 2 diabetes mellitus	8.85e-05	0.000416	CcSEcCtD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	8.84e-05	0.00219	CbGpPWpGaD
Lomefloxacin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.000416	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8.82e-05	0.00219	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8.82e-05	0.00219	CbGpPWpGaD
Lomefloxacin—Malaise—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000414	CcSEcCtD
Lomefloxacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.000414	CcSEcCtD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CAT—type 2 diabetes mellitus	8.77e-05	0.00218	CbGpPWpGaD
Lomefloxacin—Rash—Glyburide—type 2 diabetes mellitus	8.77e-05	0.000413	CcSEcCtD
Lomefloxacin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000413	CcSEcCtD
Lomefloxacin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.76e-05	0.000412	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—type 2 diabetes mellitus	8.76e-05	0.00217	CbGpPWpGaD
Lomefloxacin—Vertigo—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000412	CcSEcCtD
Lomefloxacin—Syncope—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000412	CcSEcCtD
Lomefloxacin—Leukopenia—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000411	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	8.72e-05	0.00217	CbGpPWpGaD
Lomefloxacin—Headache—Glyburide—type 2 diabetes mellitus	8.72e-05	0.00041	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—FAS—type 2 diabetes mellitus	8.69e-05	0.00216	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000409	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	8.68e-05	0.00215	CbGpPWpGaD
Lomefloxacin—Hypotension—Losartan—type 2 diabetes mellitus	8.67e-05	0.000408	CcSEcCtD
Lomefloxacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.61e-05	0.000405	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.59e-05	0.00213	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000403	CcSEcCtD
Lomefloxacin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000403	CcSEcCtD
Lomefloxacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000402	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.55e-05	0.000402	CcSEcCtD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	8.52e-05	0.00212	CbGpPWpGaD
Lomefloxacin—Cough—Ramipril—type 2 diabetes mellitus	8.51e-05	0.0004	CcSEcCtD
Lomefloxacin—Fatigue—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.0004	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.46e-05	0.000398	CcSEcCtD
Lomefloxacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.46e-05	0.000398	CcSEcCtD
Lomefloxacin—Convulsion—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000398	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—AGER—type 2 diabetes mellitus	8.45e-05	0.0021	CbGpPWpGaD
Lomefloxacin—Constipation—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000397	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	8.41e-05	0.00209	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	8.4e-05	0.00208	CbGpPWpGaD
Lomefloxacin—Insomnia—Losartan—type 2 diabetes mellitus	8.4e-05	0.000395	CcSEcCtD
Lomefloxacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.36e-05	0.000393	CcSEcCtD
Lomefloxacin—Paraesthesia—Losartan—type 2 diabetes mellitus	8.34e-05	0.000392	CcSEcCtD
Lomefloxacin—Urticaria—Metformin—type 2 diabetes mellitus	8.3e-05	0.000391	CcSEcCtD
Lomefloxacin—Arthralgia—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000391	CcSEcCtD
Lomefloxacin—Chest pain—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000391	CcSEcCtD
Lomefloxacin—Myalgia—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000391	CcSEcCtD
Lomefloxacin—Dyspnoea—Losartan—type 2 diabetes mellitus	8.28e-05	0.000389	CcSEcCtD
Lomefloxacin—Anxiety—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000389	CcSEcCtD
Lomefloxacin—Nausea—Glyburide—type 2 diabetes mellitus	8.26e-05	0.000389	CcSEcCtD
Lomefloxacin—Abdominal pain—Metformin—type 2 diabetes mellitus	8.26e-05	0.000389	CcSEcCtD
Lomefloxacin—Dizziness—Gliclazide—type 2 diabetes mellitus	8.26e-05	0.000389	CcSEcCtD
Lomefloxacin—Somnolence—Losartan—type 2 diabetes mellitus	8.25e-05	0.000388	CcSEcCtD
Lomefloxacin—Asthenia—Valsartan—type 2 diabetes mellitus	8.24e-05	0.000388	CcSEcCtD
Lomefloxacin—Discomfort—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000386	CcSEcCtD
Lomefloxacin—Dyspepsia—Losartan—type 2 diabetes mellitus	8.17e-05	0.000385	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—MTR—type 2 diabetes mellitus	8.14e-05	0.00202	CbGpPWpGaD
Lomefloxacin—Asthenia—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000383	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—LPL—type 2 diabetes mellitus	8.13e-05	0.00202	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.13e-05	0.000382	CcSEcCtD
Lomefloxacin—Pruritus—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000382	CcSEcCtD
Lomefloxacin—Dry mouth—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000382	CcSEcCtD
Lomefloxacin—Decreased appetite—Losartan—type 2 diabetes mellitus	8.07e-05	0.00038	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.00038	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.07e-05	0.002	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.05e-05	0.002	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	8.03e-05	0.00199	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—type 2 diabetes mellitus	8.03e-05	0.00199	CbGpPWpGaD
Lomefloxacin—Confusional state—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000378	CcSEcCtD
Lomefloxacin—Pruritus—Orlistat—type 2 diabetes mellitus	8.02e-05	0.000378	CcSEcCtD
Lomefloxacin—Fatigue—Losartan—type 2 diabetes mellitus	8e-05	0.000377	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—LEP—type 2 diabetes mellitus	7.97e-05	0.00198	CbGpPWpGaD
Lomefloxacin—Oedema—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000375	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000375	CcSEcCtD
Lomefloxacin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.000374	CcSEcCtD
Lomefloxacin—Constipation—Losartan—type 2 diabetes mellitus	7.94e-05	0.000374	CcSEcCtD
Lomefloxacin—Rash—Gliclazide—type 2 diabetes mellitus	7.88e-05	0.000371	CcSEcCtD
Lomefloxacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.87e-05	0.00037	CcSEcCtD
Lomefloxacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.85e-05	0.00037	CcSEcCtD
Lomefloxacin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000369	CcSEcCtD
Lomefloxacin—Shock—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000368	CcSEcCtD
Lomefloxacin—Headache—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000368	CcSEcCtD
Lomefloxacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.000367	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000367	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.77e-05	0.00193	CbGpPWpGaD
Lomefloxacin—Tachycardia—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000366	CcSEcCtD
Lomefloxacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000365	CcSEcCtD
Lomefloxacin—Skin disorder—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000364	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—type 2 diabetes mellitus	7.73e-05	0.00192	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000362	CcSEcCtD
Lomefloxacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.65e-05	0.00036	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.59e-05	0.000357	CcSEcCtD
Lomefloxacin—Dizziness—Valsartan—type 2 diabetes mellitus	7.59e-05	0.000357	CcSEcCtD
Lomefloxacin—Anorexia—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000357	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.56e-05	0.00188	CbGpPWpGaD
Lomefloxacin—Dizziness—Orlistat—type 2 diabetes mellitus	7.5e-05	0.000353	CcSEcCtD
Lomefloxacin—Asthenia—Metformin—type 2 diabetes mellitus	7.5e-05	0.000353	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.45e-05	0.00185	CbGpPWpGaD
Lomefloxacin—Hypotension—Ramipril—type 2 diabetes mellitus	7.44e-05	0.00035	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	7.43e-05	0.00184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	7.42e-05	0.00184	CbGpPWpGaD
Lomefloxacin—Nausea—Gliclazide—type 2 diabetes mellitus	7.42e-05	0.000349	CcSEcCtD
Lomefloxacin—Pruritus—Metformin—type 2 diabetes mellitus	7.4e-05	0.000348	CcSEcCtD
Lomefloxacin—Urticaria—Losartan—type 2 diabetes mellitus	7.38e-05	0.000347	CcSEcCtD
Lomefloxacin—Abdominal pain—Losartan—type 2 diabetes mellitus	7.34e-05	0.000345	CcSEcCtD
Lomefloxacin—Vomiting—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000343	CcSEcCtD
Lomefloxacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000342	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000341	CcSEcCtD
Lomefloxacin—Rash—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000341	CcSEcCtD
Lomefloxacin—Dermatitis—Valsartan—type 2 diabetes mellitus	7.23e-05	0.00034	CcSEcCtD
Lomefloxacin—Vomiting—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000339	CcSEcCtD
Lomefloxacin—Insomnia—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000339	CcSEcCtD
Lomefloxacin—Headache—Valsartan—type 2 diabetes mellitus	7.19e-05	0.000338	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.19e-05	0.00178	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.19e-05	0.00178	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	7.17e-05	0.00178	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Metformin—type 2 diabetes mellitus	7.15e-05	0.000337	CcSEcCtD
Lomefloxacin—Rash—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000336	CcSEcCtD
Lomefloxacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000336	CcSEcCtD
Lomefloxacin—Dermatitis—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000336	CcSEcCtD
Lomefloxacin—Headache—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000334	CcSEcCtD
Lomefloxacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000334	CcSEcCtD
Lomefloxacin—Asthenia—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000333	CcSEcCtD
Lomefloxacin—Somnolence—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000333	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PSMD6—type 2 diabetes mellitus	7.05e-05	0.00175	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.01e-05	0.00033	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	6.98e-05	0.00173	CbGpPWpGaD
Lomefloxacin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000328	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	6.94e-05	0.00172	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000326	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.92e-05	0.00172	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.92e-05	0.00172	CbGpPWpGaD
Lomefloxacin—Dizziness—Metformin—type 2 diabetes mellitus	6.91e-05	0.000325	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	6.91e-05	0.00171	CbGpPWpGaD
Lomefloxacin—Fatigue—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000323	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	6.86e-05	0.0017	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.84e-05	0.000322	CcSEcCtD
Lomefloxacin—Nausea—Valsartan—type 2 diabetes mellitus	6.82e-05	0.000321	CcSEcCtD
Lomefloxacin—Constipation—Ramipril—type 2 diabetes mellitus	6.81e-05	0.00032	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.8e-05	0.00169	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000318	CcSEcCtD
Lomefloxacin—Nausea—Orlistat—type 2 diabetes mellitus	6.74e-05	0.000317	CcSEcCtD
Lomefloxacin—Asthenia—Losartan—type 2 diabetes mellitus	6.66e-05	0.000313	CcSEcCtD
Lomefloxacin—Vomiting—Metformin—type 2 diabetes mellitus	6.65e-05	0.000313	CcSEcCtD
Lomefloxacin—Rash—Metformin—type 2 diabetes mellitus	6.59e-05	0.00031	CcSEcCtD
Lomefloxacin—Dermatitis—Metformin—type 2 diabetes mellitus	6.58e-05	0.00031	CcSEcCtD
Lomefloxacin—Pruritus—Losartan—type 2 diabetes mellitus	6.57e-05	0.000309	CcSEcCtD
Lomefloxacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000309	CcSEcCtD
Lomefloxacin—Headache—Metformin—type 2 diabetes mellitus	6.55e-05	0.000308	CcSEcCtD
Lomefloxacin—Dizziness—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000307	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000306	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.47e-05	0.0016	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Losartan—type 2 diabetes mellitus	6.35e-05	0.000299	CcSEcCtD
Lomefloxacin—Urticaria—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000298	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PSMD6—type 2 diabetes mellitus	6.3e-05	0.00156	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000296	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.28e-05	0.00156	CbGpPWpGaD
Lomefloxacin—Vomiting—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000295	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	6.26e-05	0.00155	CbGpPWpGaD
Lomefloxacin—Rash—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000293	CcSEcCtD
Lomefloxacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000292	CcSEcCtD
Lomefloxacin—Nausea—Metformin—type 2 diabetes mellitus	6.21e-05	0.000292	CcSEcCtD
Lomefloxacin—Headache—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000291	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.17e-05	0.00153	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.17e-05	0.00153	CbGpPWpGaD
Lomefloxacin—Dizziness—Losartan—type 2 diabetes mellitus	6.14e-05	0.000289	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.03e-05	0.0015	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.99e-05	0.00149	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	5.99e-05	0.00149	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.96e-05	0.00148	CbGpPWpGaD
Lomefloxacin—Vomiting—Losartan—type 2 diabetes mellitus	5.9e-05	0.000278	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.88e-05	0.00146	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000276	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	5.86e-05	0.00146	CbGpPWpGaD
Lomefloxacin—Nausea—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000276	CcSEcCtD
Lomefloxacin—Rash—Losartan—type 2 diabetes mellitus	5.85e-05	0.000275	CcSEcCtD
Lomefloxacin—Dermatitis—Losartan—type 2 diabetes mellitus	5.85e-05	0.000275	CcSEcCtD
Lomefloxacin—Headache—Losartan—type 2 diabetes mellitus	5.82e-05	0.000274	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—type 2 diabetes mellitus	5.75e-05	0.00143	CbGpPWpGaD
Lomefloxacin—Asthenia—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000269	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	5.69e-05	0.00141	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.68e-05	0.00141	CbGpPWpGaD
Lomefloxacin—Pruritus—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000265	CcSEcCtD
Lomefloxacin—Nausea—Losartan—type 2 diabetes mellitus	5.51e-05	0.000259	CcSEcCtD
Lomefloxacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000256	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	5.28e-05	0.00131	CbGpPWpGaD
Lomefloxacin—Dizziness—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000248	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.25e-05	0.0013	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	5.15e-05	0.00128	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND2—type 2 diabetes mellitus	5.14e-05	0.00128	CbGpPWpGaD
Lomefloxacin—Vomiting—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000238	CcSEcCtD
Lomefloxacin—Rash—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000236	CcSEcCtD
Lomefloxacin—Dermatitis—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000236	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.01e-05	0.00124	CbGpPWpGaD
Lomefloxacin—Headache—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000235	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.94e-05	0.00123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—type 2 diabetes mellitus	4.93e-05	0.00122	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.87e-05	0.00121	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—type 2 diabetes mellitus	4.81e-05	0.00119	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.8e-05	0.00119	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—MTR—type 2 diabetes mellitus	4.76e-05	0.00118	CbGpPWpGaD
Lomefloxacin—Nausea—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000222	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.73e-05	0.00117	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—type 2 diabetes mellitus	4.67e-05	0.00116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.61e-05	0.00114	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2B—type 2 diabetes mellitus	4.61e-05	0.00114	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	4.6e-05	0.00114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.55e-05	0.00113	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.51e-05	0.00112	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.51e-05	0.00112	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	4.5e-05	0.00112	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.48e-05	0.00111	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.41e-05	0.00109	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.38e-05	0.00109	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	4.37e-05	0.00108	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.36e-05	0.00108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	4.32e-05	0.00107	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.14e-05	0.00103	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.12e-05	0.00102	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.11e-05	0.00102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	4.09e-05	0.00102	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.08e-05	0.00101	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—type 2 diabetes mellitus	4.05e-05	0.00101	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.03e-05	0.001	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PPP2CA—type 2 diabetes mellitus	4.02e-05	0.000999	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.95e-05	0.000979	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.84e-05	0.000953	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.84e-05	0.000953	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.81e-05	0.000945	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	3.79e-05	0.000941	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—type 2 diabetes mellitus	3.78e-05	0.000938	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	3.78e-05	0.000938	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.75e-05	0.000932	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.69e-05	0.000915	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—type 2 diabetes mellitus	3.68e-05	0.000913	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP3A4—type 2 diabetes mellitus	3.67e-05	0.000911	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.66e-05	0.000909	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	3.62e-05	0.000898	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	3.57e-05	0.000886	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.51e-05	0.000871	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PRKCB—type 2 diabetes mellitus	3.39e-05	0.000841	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	3.38e-05	0.000838	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.33e-05	0.000826	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	3.31e-05	0.000822	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	3.31e-05	0.000822	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	3.18e-05	0.00079	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	3.15e-05	0.000783	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	3.15e-05	0.000783	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.12e-05	0.000775	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	3.1e-05	0.00077	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.03e-05	0.000751	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.01e-05	0.000747	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.99e-05	0.000741	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	2.98e-05	0.000739	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	2.96e-05	0.000735	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	2.96e-05	0.000735	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	2.96e-05	0.000735	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	2.95e-05	0.000731	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.89e-05	0.000716	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.89e-05	0.000716	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.86e-05	0.00071	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.85e-05	0.000706	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.7e-05	0.000669	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	2.68e-05	0.000666	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	2.64e-05	0.000655	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	2.63e-05	0.000654	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.47e-05	0.000614	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.43e-05	0.000604	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.28e-05	0.000566	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.24e-05	0.000557	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.24e-05	0.000557	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	2.2e-05	0.000546	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.92e-05	0.000477	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.92e-05	0.000477	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.83e-05	0.000454	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.82e-05	0.000452	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.82e-05	0.000452	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.81e-05	0.000449	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.78e-05	0.000442	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.77e-05	0.00044	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.74e-05	0.000432	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.72e-05	0.000427	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.61e-05	0.000398	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.61e-05	0.000398	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.6e-05	0.000397	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.57e-05	0.000389	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.55e-05	0.000386	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.55e-05	0.000385	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.55e-05	0.000385	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.55e-05	0.000385	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.55e-05	0.000385	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.55e-05	0.000385	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.5e-05	0.000373	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.42e-05	0.000352	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.42e-05	0.000352	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.38e-05	0.000343	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.32e-05	0.000327	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.32e-05	0.000327	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.32e-05	0.000327	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.26e-05	0.000314	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.26e-05	0.000314	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.22e-05	0.000302	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.22e-05	0.000302	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.2e-05	0.000297	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.19e-05	0.000296	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.17e-05	0.000292	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.17e-05	0.000292	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.17e-05	0.000292	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.14e-05	0.000283	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.1e-05	0.000274	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.09e-05	0.00027	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.06e-05	0.000263	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.03e-05	0.000257	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.03e-05	0.000256	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	9.99e-06	0.000248	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	9.99e-06	0.000248	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	9.99e-06	0.000248	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	9.99e-06	0.000248	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.61e-06	0.000238	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	9.58e-06	0.000238	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.3e-06	0.000231	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.12e-06	0.000226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.01e-06	0.000224	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	8.9e-06	0.000221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	8.31e-06	0.000206	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	8.14e-06	0.000202	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.14e-06	0.000202	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.99e-06	0.000198	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.94e-06	0.000197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.94e-06	0.000197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.94e-06	0.000197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.94e-06	0.000197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	7.89e-06	0.000196	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	7.75e-06	0.000192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	7.66e-06	0.00019	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.14e-06	0.000177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.12e-06	0.000177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.12e-06	0.000177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.12e-06	0.000177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.99e-06	0.000173	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.92e-06	0.000172	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.83e-06	0.000169	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.78e-06	0.000168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.51e-06	0.000162	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.44e-06	0.00016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.28e-06	0.000156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.25e-06	0.000155	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.17e-06	0.000153	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.17e-06	0.000153	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.32e-06	0.000132	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.32e-06	0.000132	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.3e-06	0.000131	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.22e-06	0.00013	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.07e-06	0.000126	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.93e-06	0.000122	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.84e-06	0.00012	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.74e-06	0.000118	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.72e-06	0.000117	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.6e-06	0.000114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.54e-06	0.000113	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.36e-06	0.000108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.28e-06	0.000106	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.14e-06	0.000103	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.07e-06	0.000101	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.06e-06	0.000101	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.01e-06	9.96e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.54e-06	8.78e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.47e-06	8.61e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.18e-06	7.89e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.04e-06	7.55e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.04e-06	7.55e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.78e-06	6.9e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.4e-06	3.47e-05	CbGpPWpGaD
